Safety and tolerability of atypical antipsychotics in the treatment of bipolar depression: A systematic review and meta-analysis of placebo-controlled monotherapy and adjunctive therapy trials

被引:0
|
作者
Hagi, K. [1 ]
Nosaka, T. [1 ]
Pikalov, A. [2 ,3 ]
Loebel, A. [2 ,3 ]
机构
[1] Sumitomo Dainippon Pharma Co Ltd, Med Affairs, Tokyo, Japan
[2] Sunov Pharmaceut Inc, Marlborough, MA USA
[3] Sunov Pharmaceut Inc, Ft Lee, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-153
引用
收藏
页码:129 / 130
页数:2
相关论文
共 50 条
  • [41] Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials
    Zis, Panagiotis
    Shafique, Faiza
    Hadjivassiliou, Marios
    Blackburn, Daniel
    Venneri, Annalena
    Iliodromiti, Stamatina
    Mitsikostas, Dimos-Dimitrios
    Sarrigiannis, Ptolemaios G.
    NEUROMODULATION, 2020, 23 (03): : 291 - 300
  • [42] The safety and tolerability of lumateperone 42 mg for the treatment of bipolar depression: A pooled analysis of 2 randomized placebo-controlled trials
    McElroy, Susan
    Durgam, Suresh
    Kozauer, Susan
    Chen, Richard
    Yatham, Lakshmi
    BIPOLAR DISORDERS, 2021, 23 : 68 - 69
  • [43] Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis
    De Fruyt, Juergen
    Deschepper, Ellen
    Audenaert, Kurt
    Constant, Eric
    Floris, Michel
    Pitchot, William
    Sienaert, Pascal
    Souery, Daniel
    Claes, Stephan
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (05) : 603 - 617
  • [44] Adjunctive antidepressants for the acute treatment of bipolar depression: A systematic review and meta-analysis
    Hu, Yuliang
    Zhang, Huijuan
    Wang, Hongyan
    Wang, Chris
    Kung, Simon
    Li, Chunbo
    PSYCHIATRY RESEARCH, 2022, 311
  • [45] Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Lam, Raymond W.
    Teng, Minnie Y.
    Jung, Young-Eun
    Evans, Vanessa C.
    Gottlieb, John F.
    Chakrabarty, Trisha
    Michalak, Erin E.
    Murphy, Jill K.
    Yatham, Lakshmi N.
    Sit, Dorothy K.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2020, 65 (05): : 290 - 300
  • [46] The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
    Hulshof, Tessa A.
    Zuidema, Sytse U.
    Ostelo, Raymond W. J. G.
    Luijendijk, Hendrika J.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2015, 16 (10) : 817 - 824
  • [47] The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials
    Fusar-Poli, Laura
    Surace, Teresa
    Vanella, Antonio
    Meo, Valeria
    Patania, Federica
    Furnari, Rosaria
    Signorelli, Maria Salvina
    Aguglia, Eugenio
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 252 : 334 - 349
  • [48] Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials
    Oya, Kazuto
    Matsuda, Yuki
    Matsunaga, Shinji
    Kishi, Taro
    Iwata, Nakao
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (05) : 439 - 450
  • [49] Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials
    Kazuto Oya
    Yuki Matsuda
    Shinji Matsunaga
    Taro Kishi
    Nakao Iwata
    European Archives of Psychiatry and Clinical Neuroscience, 2016, 266 : 439 - 450
  • [50] Meta-analysis of Dropout Rates in Placebo-Controlled Randomized Clinical Trials of Atypical Antipsychotics Assessed by PANSS
    Akiko Matsusaki
    Masayuki Kaneko
    Mamoru Narukawa
    Clinical Drug Investigation, 2019, 39 : 917 - 926